Quality of Life Predicts Chemo Tolerance in Early Breast Cancer
Fatigue and poor physical functioning before starting treatment for early breast cancer were independently associated with chemotherapy dose reductions and post-chemotherapy toxicities, a new analysis found.
Baseline quality-of-life measures, most often fatigue and physical functioning, have "been associated with survival in various cancers," the authors explain. These latest findings signal that assessing fatigue and physical functioning prior to treatment "could help to identify patients who are at risk for poor chemotherapy tolerability."
The findings were published online earlier this month in the journal Cancer.
Vous désirez lire la suite de cet article ?
Inscrivez-vous